Allogene Therapeutics to present at major investor conferences in Nov-Dec 2026
Alpha Vantage · Pluang · · AI-summarised by FinFlash
Allogene Therapeutics, a biotech company, announced its participation in three major investor conferences in November and December 2026: the UBS Global Biopharma Conference, Jefferies Global Healthcare Conference, and Piper Sandler Healthcare Conference. The company will provide live webcasts and replays, updating investors on its progress in developing allogeneic CAR T therapies for cancer and autoimmune diseases.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.